These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 30268126

  • 21. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Eissa S, Matboli M, Essawy NO, Kotb YM.
    Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
    [Abstract] [Full Text] [Related]

  • 22. Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer.
    Oehme F, Krahl S, Gyorffy B, Muessle B, Rao V, Greif H, Ziegler N, Lin K, Thepkaysone ML, Polster H, Tonn T, Schneider M, Weitz J, Baenke F, Kahlert C.
    RNA Biol; 2019 Oct; 16(10):1339-1345. PubMed ID: 31251124
    [Abstract] [Full Text] [Related]

  • 23. Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder.
    Li Z, Wang KE, Zhou XL, Zhou J, Ye CH.
    Med Sci Monit; 2018 Jan 23; 24():438-447. PubMed ID: 29358570
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
    Kim WT, Jeong P, Yan C, Kim YH, Lee IS, Kang HW, Kim YJ, Lee SC, Kim SJ, Kim YT, Moon SK, Choi YH, Kim IY, Yun SJ, Kim WJ.
    Oncotarget; 2016 Sep 06; 7(36):58193-58202. PubMed ID: 27528424
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis.
    Liu A, Zhang Z, Xu W, Qin S, Hua M, Zeng S, Xu C.
    Mol Med Rep; 2018 Dec 06; 18(6):5437-5444. PubMed ID: 30365104
    [Abstract] [Full Text] [Related]

  • 33. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
    Zhang S, Zhong G, He W, Yu H, Huang J, Lin T.
    J Urol; 2016 Oct 06; 196(4):1270-8. PubMed ID: 27267320
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T, Xie W, Xie L, Sun Y, Zhang Y, Shen Z, Sha N, Xu H, Wu Z, Hu H, Wu C.
    Biochem Biophys Res Commun; 2015 Dec 25; 468(4):666-70. PubMed ID: 26551459
    [Abstract] [Full Text] [Related]

  • 39. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
    Pichler R, Fritz J, Tulchiner G, Klinglmair G, Soleiman A, Horninger W, Klocker H, Heidegger I.
    BJU Int; 2018 Jan 25; 121(1):29-37. PubMed ID: 28941000
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.